Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Condition:   Mild Cognitive Impairment Interventions:   Drug: T-817MA;   Drug: Placebo Sponsor:   FUJIFILM Toyama Chemical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials